司法部更新 7-OH 紧急列管行动 DEA 将按浓度阈值区分增强型产品
美国司法部10月9日宣布，缉毒局（DEA）将就 7-OH 及相关阿片类物质发出新的意向通知。此次调整依据卫生与公众服务部（HHS）的更新科学建议，重点是区分天然植物成分中可能存在的微量物质，与被人为增强或浓缩的产品。
根据司法部公布内容，HHS 建议以浓度或比例阈值判断是否纳入第一类管制：固体产品超过每克1毫克、液体产品超过每毫升1毫克，或相关比例低于100比1时，可触发管制。司法部同时表示，MGPI、MGM-15 与 MGM-16 此前已临时列入第一类，相关控制在新的通知期和后续临时列管令发布前继续有效。（资料来源：美国司法部，2026年10月9日）
DOJ Updates Emergency Scheduling Action for 7-OH, With Threshold Approach
The U.S. Department of Justice announced on Oct. 9 that the Drug Enforcement Administration will issue new Notices of Intent for 7-OH and related opioid substances. The update follows revised scientific advice from the Department of Health and Human Services, aimed at distinguishing trace amounts that may occur in botanical material from products intentionally enhanced or concentrated.
According to DOJ, HHS recommended Schedule I control when the substances exceed 1 milligram per gram in solid products or 1 milligram per milliliter in liquid products, or when the relevant ratio falls below 100 to 1. DOJ also said MGPI, MGM-15 and MGM-16 were temporarily placed in Schedule I on Aug. 26, 2026, and those controls remain in effect during the new notice period and until DEA issues a new temporary scheduling order. (Source: U.S. Department of Justice, Oct. 9, 2026)
图片来源：图片来源：Openverse · Boston Public Library（CC BY）